Medsafe has opened a consultation on proposals to reduce barriers to accessing clozapine, a medicine used to treat treatment-resistant schizophrenia.

A formal regulatory inspection of Canterbury-based mental health services has set out a series of recommended changes for Health New Zealand and is continuing checks over the next 12 months.

This report is the result of an inspection of Canterbury – Waitaha adult inpatient and associated mental health services. The Director of Mental Health has powers under section 99 of the Mental Health ...

In addition to the briefings published below, we also publish additional information alongside Cabinet material, including briefings to Ministers. These can be found at Information releases.Some parts ...

Residential disability services must notify the Ministry of Health before undertaking any of the following changes: changing patient or client capacity transferring existing clinical services ...

This framework contains information for health professionals and the public on the standards they should expect for evidence-based assessment, diagnosis, and treatment for ADHD in New Zealand.

The Public Health Guidance for Hairdressers and Barbers outlines practical actions that hairdressers and barbers can take to reduce the spread of infection.

The Registrar (assisted dying) Annual Report to the Minister of Health covers the period from 1 April 2024 to 31 March 2025.

The Director for Radiation Safety is reviewing the Code of Practice for Sealed Radioactive Material: ORS C12 2020. The review is being conducted in accordance with section 90 of the Radiation Safety ...

This publication summarises funding to Māori health providers by the Ministry of Health, Health NZ and the now disestablished Māori Health Authority. It follows on from our previous reports in 2017, ...

Medsafe has given a New Zealand psychiatrist approval to prescribe medicinal psilocybin for treating treatment-resistant depression.